Objective: To determine the efficacy and dermal tolerance of a novel alcohol-based skin antiseptic (ABSA) in horses.
| I NTRO DUC TI ON
Aseptic preparation of the patient's skin is an essential step in the prevention of surgical site infections (SSI). [1] [2] [3] Many studies have attempted to establish the optimum preoperative
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skin preparation protocol for the patient, both human 2 and veterinary, 1, [3] [4] [5] [6] [7] [8] [9] [10] as well as for the surgeon. [11] [12] [13] The variables most commonly investigated include minimum contact time required and product used. The contact time required to achieve a sterile surgical field should ideally be as short as possible, especially in horses undergoing general anesthesia because perioperative mortality increases with anesthetic duration.
14 Preparation protocols that use 4% chlorhexidine gluconate (CHXG) have been found effective with contact times as short as 4 minutes for the patient 1 and 2 minutes for the surgeon. 13 Similarly, three 30-second scrubs with povidine-iodine (PI) have been found to be as effective as a 10-minute scrub or the application of a commercial 1-step PI solution in horses. 10 Interest in the use of alcohol-based skin antiseptics (ABSA) has recently increased 11, 12, 15 because studies have found them as effective but faster than traditional antiseptic products in preparing the veterinary surgeon. 12 However, their efficacy on
animal skin has not been tested, and their potential superiority compared with standard protocols remains uncertain. In addition to contact time, antiseptics should be selected for dermal tolerance on the patient's and surgeon's skin. Aseptic skin preparation may indeed induce skin reaction in patients 1-3 and surgeons. 13 Osuna et al 7, 8 established that CHXG is better tolerated than PI in the preoperative preparation of dogs, but no objective data exist regarding the tolerance of either traditional antiseptics or ABSA in horses.
The alcohol-based products that have been previously investigated 11, 12 are designed for preoperative preparation of the surgeon and are not intended for use on the patient. 16, 17 The ABSA used in this study (Cutasept F; BODE-Chemie, Hamburg, Germany) has been reported as efficacious and well tolerated in human patients. 18 This noncolored skin antiseptic contains propan-2-ol (72%) and benzalkonium chloride (<1%). The recommended contact time is 2 minutes for skin that is rich in sebaceous glands, 19 which is the case with equine skin. The objective of this study was to determine the efficacy of an ABSA in reducing the skin microbial burden in horses compared with another commonly used skin antiseptic (CHXG) and a control (saline) and to report on the dermal tolerance of these methods. We hypothesized that preparation with the ABSA would be as effective but faster than a standard CHXG skin preparation and would be well tolerated by horses.
| M ATE RI ALS AN D ME THO DS
This study was approved by the University of Bristol Animal Welfare and Ethical Review Body. Written informed consent was obtained from the owner of each horse prior to participation in the study.
| Skin preparation
Systemically healthy horses with no history or clinical signs of skin disease were included in the study. The mid-toventral abdomen was brushed 5 times with a clean, soft brush in the direction of hair growth to remove any gross debris. Four sites measuring 5 3 5 cm were then clipped with a No. 40 clipper blade, approximately 5 cm apart from cranial to caudal, on the mid-to-ventral abdomen ( Figure 1 ) and numbered consecutively from 1 (closest to elbow) to 4 (closest to flank). Each site was randomly assigned (www. randomizer.org) to 1 of 4 skin preparation methods, and all skin preparations were conducted by a single operator wearing sterile gloves. The time required to obtain grossly clean swabs during the negative control (NC) and ABSA methods was noted.
| Negative control (NC)
The site was scrubbed in a circular motion, focused around the central point with gauze swabs soaked in sterile saline until the used swabs appeared grossly clean after use. The site was then dried with 2 dry sterile gauze swabs.
| Positive control (PC)
The site was scrubbed in a circular motion, focused around the central point with gauze swabs soaked in 4% chlorhexidine gluconate (Vetasept chlorhexidine surgical scrub; Animalcare, York, United Kingdom). Each swab was used for 30 seconds, and 10 swabs were used, giving a total scrub time of 5 minutes. Excess lather was then removed from the site with 2 sterile gauze swabs soaked in 70% isopropyl alcohol, and the site was allowed to dry by evaporation. The site was scrubbed in a circular motion, focused around the central point with gauze swabs soaked in sterile saline until the used swabs appeared grossly clean after use. The site was then dried with 2 dry sterile gauze swabs. Sterile gauze swabs soaked in the ABSA (Cutasept F) were applied to the site, ensuring continual wetting for 2 minutes, and the site was allowed to dry by evaporation.
| ABSA B
The site was scrubbed in a circular motion, focused around the central point with gauze swabs soaked in a commercially available horse shampoo (Gallop Conditioning Shampoo; Carr & Day & Martin, Lytham, United Kingdom) until the used swabs appeared grossly clean after use. Excess lather was then removed from the site with 2 swabs soaked in tap water, and the site was dried with 2 dry gauze swabs. Gauze swabs soaked in the ABSA (Cutasept F) were applied to the site, ensuring continual wetting for 2 minutes, and the site was allowed to dry by evaporation.
| Microbiological sampling
The microbiological sampling technique was similar to that used in previous veterinary studies. 5, 6, 10 Immediately following the completion of skin preparation at each site, a sterile microbiological swab was placed into 1 mL of liquid Amies preservation medium (ESwab; Copan Diagnostics, Murrieta, California) within a sterile tube. Excess moisture was removed from the swab by pressing it against the side of the tube during withdrawal. The moistened swab was then rolled 3608 on the middle of the prepared site before being returned and sealed within the tube containing the preservation medium. The process was repeated for each site, and the swabs were stored at 48C for up to 24 hours prior to laboratory testing. All sampling was conducted by a single operator.
| Microbiological testing
Each tube containing a microbiological swab was agitated for 30 seconds to distribute microbes throughout the preservation medium. A MacConkey agar plate (selective for gram-negative species) and a mannitol salt agar plate (selective for gram-positive species) were each spread evenly with 100 mL of preservation medium and incubated aerobically at 378C for 18-24 hours before the plates were inspected. Colony-forming units (CFU) were counted manually by a single operator who was blinded to the skin preparation method used.
| Dermal tolerance scoring
All sites were scored for clinical signs of a skin reaction (Table 1 ) by a single operator who was blinded to the skin preparation method used at each site:
Time A, immediately after clipping but before skin preparation Time B, immediately after skin preparation and microbiological sample collection Time C, 1 hour after skin preparation Time D, 24 hours after skin preparation
If any horse was deemed to require veterinary treatment for a skin reaction occurring as a result of skin preparation, this was undertaken at the discretion of the qualified veterinary surgeons performing the skin preparation and dermal tolerance scoring.
| Data analysis
Data were analysed in SPSS Statistics for Windows version 23.0 (IBM Corp, Armonk, New York). Categorical data were analysed by using cross-tabulation methods (Pearson v 2 and Fisher's exact test). Numerical data were tested for normality (Shapiro-Wilk) and were not found to follow a Gaussian distribution; therefore, these data were analyzed by using nonparametric tests (Mann-Whitney U and KruskalWallis). Significance was set at P < .05. For multiple, simultaneous analyses between groups, Bonferroni correction was applied.
| RES U LTS
Twenty-five horses were recruited to the study, and each horse was tested on both left and right sides, providing a total of 50 data sets. Thirteen geldings and 12 mares were included, ranging in age from 1 to 25 years (mean, 9). There were 11 native breed ponies, 9 cobs, and 5 thoroughbreds. 
| Microbiological testing
Site preparation method was correlated to the number of bacteria detected on both MacConkey (P < .001) and mannitol salt (P < .001) agar plates. The microbial burden was significantly reduced by all of the skin preparation methods by using an antiseptic product compared with the NC method, and there was no difference between antiseptics (Figures 2-3) . The PC method (300 seconds) took longer than both the ABSA A (178.1 seconds; range, 140-220; P < .001) and the ABSA B (185.7 seconds; range, 140-230; P < .001) methods, but there was no difference between the ABSA A and ABSA B methods (P 5 0.108). There was no significance of breed, coat color, side of horse, or site number on the number of bacteria on either MacConkey or mannitol salt agar plates.
| Dermal tolerance scoring
There was no correlation between site preparation method and dermal score at any time when considered overall or when analyzed between groups. A dermal tolerance score of "0" was recorded at 97.5%, 83.5%, 82%, and 69.5% of sites at times A, B, C, and D, respectively. The highest dermal tolerance score recorded was "2" (Table 1) Breed had a significant effect on dermal score at time A (P 5 0.038), although only 1 horse (a native breed pony) recorded all of the skin reactions at this time. At time D, breed was also significant (P 5 0.048), with thoroughbreds experiencing considerably more skin reactions (50.0%) than cobs (27.8%) or native breed ponies (23.9%). At time B and time C, there was no difference between breed and dermal score. Coat color was not a significant variable in relation to dermal score at any time. At time C, 75% of skin reactions occurred on the right side of the horse (P 5 0.001), but, at all other times, there was no difference between the side of the horse and dermal score.
Site number had a significant effect on dermal score at times B (P 5 0.028), C (P 5 0.001), and D (P < .001) but not at time A. Most skin reactions occurred at site number 1 at time B (45.5%), time C (50.0%), and time D (44.3%).
| DI S CU S S IO N
The main finding of this study is that the ABSA was as efficacious in reducing the microbial burden of equine skin and as well tolerated as a standard CHXG skin preparation but accelerated skin preparation for aseptic surgery in healthy horses. The ABSA tested in this study contains propan-2-ol, which acts by coagulating proteins, causing them to denature. The agent affects primarily the cell wall, cytoplasmic membrane, and plasma proteins, causing loss of cellular functions, increased permeability of the cell wall, and subsequent lysis of the organism. 20 By contrast, benzalkonium chloride disrupts intermolecular interaction, which is another mechanism leading to cell lysis. 21 When combined, these agents are bactericidal, yeasticidal, tuberculocidal, and virucidal. 19 Skin preparation with the ABSA took approximately 3 minutes (60-second scrub 1 2 minute contact time),
F IGUR E 2 Graphic representation of the number of CFU present on
MacConkey agar plates, per swab, after each skin preparation method. ABSA A, saline followed by the ABSA; ABSA B, commercially available horse shampoo followed by the ABSA; CFU, colony-forming unit; NC, negative control; PC, positive control FI GU RE 3 Graphic representation of the number of CFU present on mannitol salt agar plates, per swab, after each skin preparation method. ABSA A, saline followed by the ABSA; ABSA B, commercially available horse shampoo followed by the ABSA; CFU, colony-forming unit; NC, negative control; PC, positive control compared with a standard 5-minute CHXG skin preparation method. This reduction in skin preparation time may decrease the overall duration of anesthesia, a factor associated with perioperative mortality in horses.
14 Another advantage of ABSA preparation consists of cost benefits, in terms of staffing and materials that are required to prepare patients for aseptic surgery. We did not measure the volume of the ABSA used for each skin preparation in this study, so we cannot provide a direct cost comparison per unit area for each of the skin preparation methods tested in this study. However, the ABSA is more cost effective per milliliter than the CHXG product used, and similar overall volumes of each product were used for the study. Therefore, the cost of the ABSA seems comparable to that of CHXG, which is commonly used in veterinary practice. Shorter scrub times with CHXG have been found effective in other species, 1,13 but
have not been validated in horses.
The ABSA and CHXG protocols tested here were well tolerated on equine skin, confirming previous results in other species. Dermal tolerance is commonly reported in man 2, 18, 22 and is occasionally reported subjectively in veterinary studies, 1, 3, 7, 8, 10 but there are no objective reports for any products in horses. Irritation of the skin adjacent to a surgery site, from shaving instead of clipping for example, facilitates colonization by bacteria, thereby increasing the risk of SSI. 23 In light of these findings, selecting an antiseptic that minimizes the risk of skin irritation is relevant. The highest dermal score achieved at any time point in our study was a grade 2 of 4 (Table 1) , but skin irritation resolved without veterinary intervention in all cases. The effects of breed (detected only at time D) and side of horse (detected only at time C) are unclear in this sample set. A post hoc analysis of power was not conducted because extrapolating from our data to predict what would happen if larger numbers were included would simply maintain these significant differences. The only way to determine whether our findings were true anomalies would be to repeat the study to establish whether fresh data showed lower variance. Although skin preparation methods were randomly assigned to sites, skin reactions were more consistently recorded at site number 1. This site was always the first to be clipped when starting skin preparation; dirt and/or hair were removed from the clippers with a clean stiff brush between procedures on horses and between procedures on each side of the same horse, but no clipper lubricant was applied. A new clipper blade was applied if the current blade was deemed to be blunt and not cutting the hair adequately. We do not believe that the use of clean, sharp clippers, especially those without clipper lubricant, can explain the predisposition of site 1 to skin reactions. However, we cannot eliminate the potential causative role of other unidentified clipper-related factors. Alternatively, site 1 was closest to the elbow and so we hypothesize that the skin in this area may be more sensitive than that closer to the flank. Additional studies are required to establish the dermal tolerance of both the ABSA and CHXG on other body areas in equine patients.
Our study was designed to test an ABSA (Cutasept F) product destined for preoperative preparation of human patients. We selected a standard 5-minute CHXG scrub as reference because this method is routinely used in our equine hospital. Although the sustained action of CHXG may be reduced by rinsing with 70% isopropyl alcohol, 8, 9 this protocol is common in many hospitals and other studies. [1] [2] [3] 5, [7] [8] [9] We did not intend to test the residual action of antiseptics and, therefore, adopted this method of rinsing CHXG to maintain clinical applicability. The protocol for microbiological testing is similar to that used in other veterinary studies that have compared the efficacy of antiseptic methods. 5, 6, 10 However, we did not conduct preantiseptic microbiological sampling, which was used in other studies to calculate the percentage of CFU reduction. 1, [3] [4] [5] [6] [7] [8] [9] [10] This design was selected because we sought to compare the activity of 4 skin antiseptic methods, not to establish the final efficacy of the methods in preventing SSI. The physical process of conducting preantiseptic microbiological sampling will inherently reduce the microbial burden of the skin, thereby giving a false result in terms of the overall number of CFU and of the percentage of CFU reduction. Also, to the best of our knowledge, the number of CFU required to initiate an SSI remains unknown. Determining the percentage of CFU reduction is therefore not required in this experimental study if the level of postantiseptic CFU deemed acceptable is unknown. However, if the ABSA methods were to prove as effective at reducing skin microbial burden as CHXG at a single time point in this study, we could extrapolate that the ABSA would be safe enough to use in a clinical trial to establish its efficacy in reducing SSI. We chose to examine the microbiological samples for common bacteriagram positive and gram negative-to establish the basic effect of the skin preparation methods. The use of MacConkey (selective for Enterobacteriaceae species) and mannitol salt (selective for Staphylococcus species) agar plates implies that some bacteria involved in SSI may not have been detected in our study. However, we did not intend to establish the efficacy of our skin preparation methods in preventing SSI. A larger study with prepreparation microbiological sampling would be required to test these antiseptic preparations on specific bacteria that are not as commonly present on equine skin but could result in SSI. Limitations of this study include the small sample of horses used and the timing of the study during summer months, when all the horses were relatively clean and dry. CFU are more abundant when cultured from unclipped contaminated rather than unclipped clean skin. 10 In addition, clipping, as performed in this study, can increase the number of prescrub CFU compared with nonclipped skin. 6 However, the number of postscrub CFU do not differ between clipped versus nonclipped skin, 6 and increased skin contamination is unlikely to affect the overall efficacy of the skin antiseptic. 10 We therefore do not believe that the timing of our study would change our results in terms of dermal tolerance and efficacy. However, our method of skin preparation required all swabs to be grossly clean after use. It is therefore possible that increased skin contamination, as seen in the winter, may prolong the average scrub time before application of ABSA. Finally, we cannot rule out that the number of CFU was reduced by continued antiseptic activity within the preservation medium or on the agar plates because we did not use antiseptic-neutralizing medium or agar. However, we expect that such an effect would be minimized by the dilution of the preservation medium and, therefore, would not affect our results.
In conclusion, the ABSA tested in this study was efficacious, fast, and well tolerated for skin antisepsis in healthy horses. These encouraging results warrant validation in clinical equine cases.
